Damien Conover, CFA

Damien Conover, CFA, is director of equity research, North America, for Morningstar.

More From Damien Conover

The drugmaker offers investors robust growth and an attractive dividend, notes Morningstar's analyst.

Morningstar's analyst says there's much more to Pfizer's products than COVID-19 vaccines and treatments.

The surprise breakup will allow both new companies to operate with more focus and agility. We don't see this impacting our fair value estimate.

We have raised our fair value estimate based on the company's strong performance.

More About Damien Conover

Damien Conover, CFA, is director of equity research, North America, for Morningstar.

Before joining Morningstar in 2007, Conover was an equity research analyst covering the healthcare sector for Raymond James, Bank of Montreal, and Tucker Anthony.

Conover holds bachelor’s and master’s degrees in finance from the University of Wisconsin and was a member of its Applied Security Analysis Program. He also holds the Chartered Financial Analyst® designation.

Sponsor Center